A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation
Clinical trial NCT02686372 · COMPLETED
Trial details
- NCT number
- NCT02686372
- Sponsor
- Lion TCR Pte. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-16
- Primary completion
- 2021-09-28
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.